unknown
Stage
About
Cell BioEngines is a clinical-stage biotech company developing allogeneic 'off-the-shelf' cell therapies by chemically reprogramming stem cells to treat serious and currently incurable diseases, focusing on scalable manufacturing and HLA-guided design for broad patient coverage.
Explore Cell BioEngines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.